Literature DB >> 33352618

Cellular and behavioral basis of cannabinioid and opioid interactions: Implications for opioid dependence and withdrawal.

Aida Mohammadkhani1, Stephanie L Borgland1.   

Abstract

The brain's endogenous opioid and endocannabinoid systems are neuromodulatory of synaptic transmission, and play key roles in pain, memory, reward, and addiction. Recent clinical and pre-clinical evidence suggests that opioid use may be reduced with cannabinoid intake. This suggests the presence of a functional interaction between these two systems. Emerging research indicates that cannabinoids and opioids can functionally interact at different levels. At the cellular level, opioid and cannabinoids can have direct receptor associations, alterations in endogenous opioid peptide or cannabinoid release, or post-receptor activation interactions via shared signal transduction pathways. At the systems level, the nature of cannabinoid and opioid interaction might differ in brain circuits underlying different behavioral phenomenon, including reward-seeking or antinociception. Given the rising use of opioid and cannabinoid drugs, a better understanding of how these endogenous signaling systems interact in the brain is of significant interest. This review focuses on the potential relationship of these neural systems in addiction-related processes.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  THC; addiction; cannabinoids; endogenous systems; interaction; opioids; withdrawal

Mesh:

Substances:

Year:  2020        PMID: 33352618     DOI: 10.1002/jnr.24770

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  4 in total

1.  Role of primary sensory neurone cannabinoid type-1 receptors in pain and the analgesic effects of the peripherally acting agonist CB-13 in mice.

Authors:  Neil C Ford; Awinita Barpujari; Shao-Qiu He; Qian Huang; Chi Zhang; Xinzhong Dong; Yun Guan; Srinivasa N Raja
Journal:  Br J Anaesth       Date:  2021-11-26       Impact factor: 11.719

Review 2.  Alternative pain management via endocannabinoids in the time of the opioid epidemic: Peripheral neuromodulation and pharmacological interventions.

Authors:  Ming Tatt Lee; Ken Mackie; Lih-Chu Chiou
Journal:  Br J Pharmacol       Date:  2021-12-07       Impact factor: 9.473

3.  Footshock-Induced Abstinence from Compulsive Methamphetamine Self-administration in Rat Model Is Accompanied by Increased Hippocampal Expression of Cannabinoid Receptors (CB1 and CB2).

Authors:  Subramaniam Jayanthi; Ritvik Peesapati; Michael T McCoy; Bruce Ladenheim; Jean Lud Cadet
Journal:  Mol Neurobiol       Date:  2022-01-03       Impact factor: 5.590

4.  The Efficacy of Cannabis in Reducing Back Pain: A Systematic Review.

Authors:  Richard L Price; Kaarina V Charlot; Sven Frieler; Joseph R Dettori; Rod Oskouian; Jens R Chapman
Journal:  Global Spine J       Date:  2022-02-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.